Most antioxidants get absorbed, used, and excreted within hours. Your body treats them as temporary guests. But there's one compound your body treats very differently — holding onto it, concentrating it in the tissues that need the most protection, and even building a dedicated transport protein just to absorb it.
That compound is ergothioneine. And the scientific community is paying serious attention.
What Is Ergothioneine?
Ergothioneine is an atypical amino acid with a uniquely stable sulfur component. Unlike most antioxidants that degrade quickly, ergothioneine remains stable in your body for extended periods. It's produced by fungi and certain soil bacteria — humans and other animals cannot make it themselves.
It was first discovered in 1909 in ergot fungi (hence the name), but for nearly a century, nobody understood why it accumulated in human tissues. That changed in 2005.
Your Body Built a Transporter Just for This
In 2005, Grundemann's research group identified a protein called OCTN1 — a dedicated transporter whose primary function is to absorb and retain ergothioneine from the diet. This was a turning point in how scientists viewed the compound.
Your body doesn't build custom transport proteins for unimportant molecules. OCTN1 is found in the gut lining, liver, kidneys, lungs, red blood cells, and brain — all tissues exposed to high levels of oxidative stress. The body is actively collecting ergothioneine and sending it where damage is most likely to occur.
This discovery led the renowned biochemist Bruce Ames to classify ergothioneine as a "longevity vitamin" — a compound that may not prevent immediate deficiency disease, but whose absence accelerates the chronic damage associated with aging.
"The body has a specific transporter for ergothioneine. It concentrates it in the cells most under threat. Biology doesn't do that for trivial reasons." — Prof. Barry Halliwell, National University of Singapore
What Does Ergothioneine Actually Do?
Ergothioneine operates through several mechanisms that make it unusual even among well-studied antioxidants.
Adaptive Antioxidant
Unlike vitamin C or vitamin E, which react with free radicals somewhat indiscriminately, ergothioneine appears to be selectively active. It targets specific forms of oxidative damage while leaving beneficial reactive oxygen species (which your body uses for signaling) intact. This "smart" antioxidant behavior is rare and valuable.
Anti-Inflammatory Action
Chronic, low-grade inflammation — sometimes called "inflammaging" — is a hallmark of biological aging. Ergothioneine has demonstrated anti-inflammatory properties in multiple cell and animal studies, potentially dampening the inflammatory pathways that accelerate tissue degradation over decades.
Metal Ion Chelation
Free iron and copper ions in your tissues can catalyze the production of highly damaging hydroxyl radicals. Ergothioneine binds these metal ions, reducing their ability to cause oxidative harm. This chelation activity adds another layer of cellular protection.
The Epidemiological Evidence
Population-level studies have found consistent associations between low blood ergothioneine levels and several age-related conditions:
- Cognitive decline and dementia — lower ergothioneine levels correlate with increased risk
- Parkinson's disease — reduced levels observed in patients compared to controls
- Macular degeneration — the eye concentrates ergothioneine via OCTN1, suggesting a protective role
- Frailty in older adults — lower levels associated with greater physical decline
Correlation isn't causation. But when the same pattern appears across multiple conditions, all involving oxidative and inflammatory damage, and the body has a specific transport system for the compound — the signal is worth investigating seriously.
An Important Safety Note: No TMAO Concerns
Some sulfur-containing compounds (like carnitine and choline) can be converted by gut bacteria into trimethylamine N-oxide (TMAO), which has been linked to cardiovascular risk. Researchers specifically investigated whether ergothioneine shares this problem.
It does not. Ergothioneine does not raise TMAO levels, giving it a clean cardiovascular safety profile that sets it apart from some other compounds in the longevity space.
The Research Pipeline
Ergothioneine isn't just a theoretical interest. It's being actively investigated in some of the most rigorous programs in longevity science.
The Intervention Testing Program (ITP)
The ITP is run by the National Institute on Aging and tests compounds for lifespan extension in genetically diverse mice across three independent laboratories simultaneously. It is considered one of the most rigorous longevity research programs in the world. Very few compounds are selected for testing. Ergothioneine is currently under investigation.
Human Clinical Trials
Professor Barry Halliwell at the National University of Singapore is running placebo-controlled clinical trials examining ergothioneine's effects on cognitive impairment. These are randomized, controlled studies — the standard that separates preliminary evidence from reliable science.
Related Research Programs
Professor Robert Beelman is studying how soil fungi interactions affect ergothioneine content in food crops — work that could influence agricultural practices. Professor Chester Drum is investigating ergothioneine's potential role in cardiac protection. The breadth of active research reflects genuine scientific confidence in this compound.
Animal Model Results
In animal studies, ergothioneine supplementation has shown promising effects on lifespan extension and improvements in both physical and cognitive function. These results are preliminary — animal models don't always translate to humans — but they're consistent with the epidemiological and mechanistic evidence.
How Much Do You Need?
Dietary intake varies widely depending on mushroom consumption:
- Low mushroom consumers: approximately 5mg per day
- High mushroom consumers: approximately 15mg per day
- Clinical trial doses: up to 25mg per day
- EFSA safety assessment: 30mg per day considered safe
The best food sources are mushrooms — particularly shiitake, oyster, and king oyster varieties. However, ergothioneine content varies significantly depending on growing conditions, soil quality, and preparation method.
Why Most Supplement Companies Don't Include It
Despite the growing evidence, ergothioneine remains absent from most supplement formulations. The reasons are straightforward: it's expensive to source at clinical doses, it's not well-known enough to drive marketing, and most companies formulate based on consumer awareness rather than scientific evidence.
Coastline includes ergothioneine at a clinical dose in its system. It's one of the ingredients that best represents our approach — following the science to compounds most people haven't heard of yet, rather than adding another form of vitamin D because it's easy to market.
Frequently Asked Questions
Can I get enough ergothioneine from diet alone?
If you eat mushrooms regularly — particularly shiitake or oyster mushrooms several times per week — you can reach meaningful intake levels. However, most Western diets provide only about 5mg daily, well below the doses used in clinical research. Cooking does not significantly destroy ergothioneine, which is unusually heat-stable.
Is ergothioneine safe for long-term use?
The European Food Safety Authority (EFSA) has assessed ergothioneine and considers 30mg per day safe. It has been consumed in the human diet for as long as humans have eaten mushrooms. No significant adverse effects have been reported in clinical trials at doses up to 25mg daily.
How is ergothioneine different from other antioxidants like vitamin C?
Three key differences. First, your body has a dedicated transporter (OCTN1) specifically for ergothioneine — it doesn't have one for vitamin C in the same way. Second, ergothioneine is far more stable and is retained in tissues for weeks rather than hours. Third, it appears to be selectively active rather than reacting broadly with all free radicals.
When will human clinical trial results be available?
Professor Halliwell's cognitive impairment trials and the ITP lifespan studies are ongoing. Results from these programs will likely emerge over the next few years. In the meantime, the combination of epidemiological data, mechanistic evidence, animal models, and the existence of a dedicated human transporter provides a strong scientific foundation.
Coastline's editorial team covers emerging longevity science in depth. We chose to include ergothioneine when most supplement companies hadn't heard of it — because the evidence, not the marketing potential, guided our formulation. See why we chose ergothioneine and every other ingredient in the Coastline system.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
